Bacteria, human microbiome

Lab Ohnmacht

Mucosal Immunology

The Ohnmacht lab aims to better understand basic immunological concepts at barrier organs such as the gut and the lung.

About our Research

The Ohnmacht lab aims to better understand basic immunological concepts at barrier organs such as the gut and the lung. At these mucosal sites, our immune system is constantly exposed to our immediate environment, including allergens, microbes and food-derived antigens. Dealing with such an enormous complexity is a challenging task for both the innate and adaptive immune system: On the one hand immune defense needs to be maintained upon encounter of pathogens; on the other hand, an enormous amount of tolerogenic antigens requires constant education of immunological tolerance mechanisms. When this immune education fails, several diseases associated with imbalanced immune tolerance can develop including inflammatory bowel disease, food allergy or asthma. The Ohnmacht lab applies state-of-the art techniques as well as in vitro and in vivo model systems to study several key cell types directly present within mucosal tissues at the cellular and molecular level.

Topics

In this ERC-funded project, we aim to elucidate the role and function of a newly discovered regulatory T cell subset present in the lamina propria of the gastrointestinal tract. This Foxp3-expressing T cell population co-expresses the transcription factor ROR gamma t (Rorc) and is induced upon microbial colonization early in life. Microbial colonization counteracts an intrinsic type 2 immune bias within the intestinal lamina propria and may thereby help to prevent sensitization and subsequent development of allergic reactions. Through the use of gnotobiotic murine models, we aim to identify microbial signatures and metabolites particularly suitable for the induction of this important cell population. On the host side, we aim to understand the cellular and molecular pathways guiding the induction and identity of this regulatory T cell population by studying T cell intrinsic molecular programs. Additionally, we are interested in which molecular switches govern the induction and maintenance of this regulatory T cell subset in dendritic cells – the main accessory cell type required for sampling, processing and presentation of foreign peptides to T cells. Finally, we study how local stromal cells may help to provide a highly tolerogenic environment for the establishment of immune tolerance within the gastrointestinal tract (see below).

Scientists at Mucosal Immunology

Caspar Ohnmacht
Dr. rer. nat. Caspar Ohnmacht

Head of Research Group Mucosal Immunology

View profile
Porträt Dr. Maria Szente-Pasztoi
Dr. rer. nat. Maria Szente-Pasztoi

Senior Scientist - Mucosal Immunology

View profile
Dr. Vandana Kumari

Scientist

Porträt Karsten Huth
Karsten Huth

PhD student

Nina Wichmann

PhD Student

Porträt Arisha Patt
Arisha Patt

PhD Student

Porträt Benjamin Schnautz
Benjamin Schnautz

Labmanager

Porträt Johanna Grosch
Johanna Grosch

Technician

Publications

Cell Rep. Med. 6:102236 (2025)

Siebert, K. ; Faro, T. ; Köhler, N. ; Hölz, H. ; Jarosch, S. ; Matchado, M. ; Häcker, D. ; De Zen, F. ; Hajji, M.S. ; Lurz, E. ; Koletzko, S. ; Pauling, J.K. ; Steiger, K. ; Neuhaus, K. ; Ohnmacht, C. ; List, M. ; Busch, D.H. ; Haller, D. ; Schwerd, T.

Endoscopic healing in pediatric IBD perpetuates a persistent signature defined by Th17 cells with molecular and microbial drivers of disease.
Eur. J. Immunol. 55:e202451273 (2025)

Kübelbeck, T. ; Wichmann, N. ; Raj, T. ; Raj, C. ; Ohnmacht, C. ; Hövelmeyer, N. ; Kramer, D. ; Heissmeyer, V.

Regulation and function of the atypical IκBs-Bcl-3, IκBNS, and IκBζ-in lymphocytes and autoimmunity.
Nat. Commun. 16:3902 (2025)

Kolland, D. ; Kuhlmann, M. ; de Almeida, G.P. ; Köhler, A. ; Arifovic, A. ; von Strempel, A. ; Pourjam, M. ; Bolsega, S. ; Wurmser, C. ; Steiger, K. ; Basic, M. ; Neuhaus, K. ; Schmidt-Weber, C.B. ; Stecher, B. ; Zehn, D. ; Ohnmacht, C.

A specific microbial consortium enhances Th1 immunity, improves LCMV viral clearance but aggravates LCMV disease pathology in mice.

Contact

Caspar Ohnmacht
Dr. rer. nat. Caspar Ohnmacht

Head of Research Group Mucosal Immunology

View profile